K. P. Johnson

4.7k citations

40 papers · 3.7k indexed · 2 hit papers · h-index 21

Impact in

Pathology and Forensic Medicine top 0.2%
- Multiple Sclerosis Research Studies
Neurology top 1%
- Peripheral Neuropathies and Disorders
- Neuroinflammation and Neurodegeneration Mechanisms

Papers in

Pathology and Forensic Medicine 22
- Multiple Sclerosis Research Studies 22
Virology 3

Co-authors: Corey C. Ford Robert P. Lisak Hillel Panitch J E Merrill David R. Hinton Florence M. Hofman J. S. Wolinsky Lawrence W. Myers
Journals: Multiple Sclerosis Journal (8 papers)Neurology (3 papers)The Journal of Infectious Diseases (3 papers)Archives of Virology (3 papers)Infection and Immunity (2 papers)
Partner nations: United States Sweden United Kingdom

In The Last Decade

K. P. Johnson

39 papers receiving 3.5k citations

Hit Papers

align trajectories log scale

Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosis 1995 · 1.5k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

1995 Neurology
1989 The Journal of Experimental Medicine

Peers

Countries citing papers authored by K. P. Johnson

Since Specialization

Citations

This map shows the geographic impact of K. P. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. P. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. P. Johnson more than expected).

Fields of papers citing papers by K. P. Johnson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. P. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. P. Johnson. The network helps show where K. P. Johnson may publish in the future.

Co-authorship network

The 25 scholars most cited alongside K. P. Johnson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with K. P. Johnson Line = papers co-authored together K. P. Johnson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Clinical response to glatiramer acetate correlates with modulation of IFN-γ and IL-4 expression in multiple sclerosis Multiple Sclerosis Journal ·Yu.A. Skomorina, Kathleen Costello, M. Chen, Areen Said, K. P. Johnson, Suhayl Dhib‐Jalbut	2007	34
2	A prospective open-label study of glatiramer acetate: over a decade of continuous use in multiple sclerosis patients Multiple Sclerosis Journal ·Corey C. Ford, K. P. Johnson, Robert P. Lisak, Hillel Panitch, Galia Shifroni, Jerry S. Wolinsky, (unknown)	2006	114
3	Neurologic consequence of delaying glatiramer acetate therapy for multiple sclerosis: 8-year data Acta Neurologica Scandinavica ·K. P. Johnson, Corey C. Ford, Robert P. Lisak, J. S. Wolinsky	2004	51
4	Glatiramer acetate (Copaxone): comparison of continuous versus delayed therapy in a six-year organized multiple sclerosis trial Multiple Sclerosis Journal ·K. P. Johnson, Benjamin Brooks, Corey C. Ford, Andrew Goodman, Robert P. Lisak, Lawrence W. Myers, Amy A. Pruitt, Marco Rizzo, John Rose, L. P. Weiner, Jerry S. Wolinsky	2003	50
5	Sustained immunological effects of Glatiramer acetate in patients with multiple sclerosis treated for over 6 years Journal of the Neurological Sciences ·Lupaşcu Mihail, Petra Turi, K. P. Johnson, Roland Martinꝉ, Suhayl Dhib‐Jalbut	2002	38
6	United States open-label glatiramer acetate extension trial for relapsing multiple sclerosis: MRI and clinical correlates Multiple Sclerosis Journal ·Jerry S. Wolinsky, Ponnada A. Narayana, K. P. Johnson	2001	69
7	Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years Multiple Sclerosis Journal ·K. P. Johnson, Benjamin Brooks, Corey C. Ford, Andrew Goodman, Joseph Guarnaccia, Robert P. Lisak, Lawrence W. Myers, Hillel Panitch, Amy A. Pruitt, John Rose, Norman J. Kachuck, J. S. Wolinsky, (unknown)	2000	170
8	The effect of vesnarinone on TNFα production in human peripheral blood mononuclear cells and microglia: a preclinical study for the treatment of multiple sclerosis Journal of Neuroimmunology ·Hong Jiang, Bibiana Bielekova, Hitoshi Okazaki, Meena Seda, K. P. Johnson, Gregory K. Bergey, Roland Martinꝉ, Suhayl Dhib‐Jalbut	1999	10
9	Role of interferons in demyelinating disease PubMed ·K. P. Johnson	1997	1
10	Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosis Neurology ·K. P. Johnson, Benjamin Brooks, J. A. Cohen, Corey C. Ford, Jonathan Goldstein, Robert P. Lisak, Lawrence W. Myers, Hillel Panitch, John Rose, Randolph B. Schiffer, Timothy R. Vollmer, L. P. Weiner, J. S. Wolinsky, (unknown) Hit paper breakdown →	1995	1476
11	A Brief History of the Use of Interferons as Treatment of Multiple Sclerosis Archives of Neurology ·L. Jacobs, K. P. Johnson	1994	39
12	The effects of 4‐aminopyridine in multiple sclerosis patients Neurology ·C. T. Bever, Douglas Young, Paul A. Anderson, Allan Krumholz, Petra Turi, James Leslie, Natalie D. Eddington, Karen I. Plaisance, Hillel Panitch, Suhayl Dhib‐Jalbut, Michael J. Fossler, John Devane, K. P. Johnson	1994	135
13	Tumor necrosis factor identified in multiple sclerosis brain. The Journal of Experimental Medicine ·Florence M. Hofman, David R. Hinton, K. P. Johnson, J E Merrill Hit paper breakdown →	1989	677
14	Five measles virus antigens demonstrated by use of mouse hybridoma antibodies in productively infected tissue culture cells Archives of Virology ·Erling Norrby, J M Vreslovic, T Togashi, Kathryn B.; id_orcid 0000-0002-3300-7220 Cunningham, K. P. Johnson	1982	73
15	Measles- or Mumps Virus-Infected Cells Forming Rosettes With Lymphocytes From Patients With Multiple Sclerosis Archives of Neurology ·Leslie H. Tobler, K. P. Johnson, Gertrude Case Buehring	1982	4
16	Measles Virus Genome in Infections of the Central Nervous System The Journal of Infectious Diseases ·Ashley T. Haase, Peggy Swoveland, Linda Stowring, P. Ventura, K. P. Johnson, Erling Norrby, C. J. Gibbs	1981	26
17	Guinea pig cytomegalovirus: Transplacental transmission Archives of Virology ·K. P. Johnson, Toru Sasaki	1979	36
18	In vitro stimulation of bovine circulating lymphocytes by parainfluenza type 3 virus Research in Veterinary Science ·K. P. Johnson, Brør Morein	1977	23
19	Cytomegalovirus Infection in Weanling Guinea Pigs The Journal of Infectious Diseases ·Toru Sasaki, K. P. Johnson	1976	19
20	Miniculture Plaquing Technique for Mouse Cytomegalovirus Applied Microbiology ·K. P. Johnson, Dariele Burchfield	1971	3

About K. P. Johnson

K. P. Johnson is a scholar working on Pathology and Forensic Medicine, Virology, Neurology, Epidemiology and Rheumatology, having authored 40 papers that have together received 3.7k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (22 papers), Virology and Viral Diseases (10 papers), Peripheral Neuropathies and Disorders (9 papers), Polyomavirus and related diseases (8 papers), Virus-based gene therapy research (5 papers), Viral Infections and Immunology Research (5 papers), Rheumatoid Arthritis Research and Therapies (5 papers) and Herpesvirus Infections and Treatments (3 papers). The work is most often cited by research in Pathology and Forensic Medicine (2.5k citations), Neurology (1.2k citations), Rheumatology (802 citations), Immunology (1.0k citations) and Neurology (395 citations). K. P. Johnson has collaborated with scholars based in United States, Sweden and United Kingdom. Frequent co-authors include Corey C. Ford, Robert P. Lisak, Hillel Panitch, J E Merrill, David R. Hinton, Florence M. Hofman, J. S. Wolinsky, Lawrence W. Myers, John Rose and Benjamin Brooks. Their work appears in journals such as Multiple Sclerosis Journal, Neurology, The Journal of Infectious Diseases, Archives of Virology and Infection and Immunity.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact